Abstract Development of a Chlamydia trachomatis vaccine has been a formidable task partly
because of an ineffective delivery system. Our laboratory has generated a recombinant …

We recently demonstrated by in vitro experiments that PLGA (poly D, L-lactide-co-glycolide)
potentiates T helper 1 (Th1) immune responses induced by a peptide derived from the …

Recently we reported the immune-potentiating capacity of a Chlamydia nanovaccine (PLGA-
rMOMP) comprising rMOMP (recombinant major outer membrane protein) encapsulated in …

Chlamydia trachomatis is a bacterial sexually transmitted infection affecting millions of
people worldwide. Previous vaccination attempts have employed the recombinant major …

PLA–PEG [poly (lactic acid)–poly (ethylene glycol)], a biodegradable copolymer, is
underexploited for vaccine delivery although it exhibits enhanced biocompatibility and slow …

Vaccine developmental strategies are utilizing antigens encapsulated in biodegradable
polymeric nanoparticles. Here, we developed a Chlamydia nanovaccine (PLGA-rMOMP) by …

Recently, we reported that our PPM chlamydial nanovaccine [a biodegradable co-polymeric
PLA-PEG (poly (lactic acid)-poly (ethylene glycol))-encapsulated M278 peptide (derived …

We previously developed a Chlamydia trachomatis nanovaccine (PPM) by encapsulating a
chlamydial M278 peptide within poly (lactic acid)-poly (ethylene glycol) biodegradable …

Introduction: There is a persisting global burden and considerable public health challenge
by the plethora of ocular, genital and respiratory diseases caused by members of the Gram …

Introduction Chlamydia trachomatis, commonly referred to as chlamydia (a bacterium), is a
common sexually transmitted infection, and if attended to early, it can be treatable. However …